Daily Cardiology

Daily Cardiology Academy
  • 4.9 (8)
  • Medicine
  • Updated Daily

to enjoy learning and progressing in cardiometabolic practice برای تبلیغات صوتی و اسپانسرینگ پادکست‌های فارسی، به شنوتو مراجعه کنید. Hosted on SHENOTO

  1. 1d ago

    ESC 2026: Evaluation of perfusion strategies in older patients

    📚 ESC 2026 coverage: In NSTEMI patients aged ≥80, can stress imaging-guided angiography replace routine angiography without worsening outcomes? By Dr. Ghanavati, cardiologist. Hosted on SHENOTO

    ESC 2026: Evaluation of perfusion strategies in older patients

  2. 1d ago

    Beyond the Guidelines: Peripheral Artery Disease

    Beyond the guidelines, there is experience. 🎙️Hear Dr. Mehdi Shishehbor’s perspective on PAD, clinical insights that go beyond the algorithms. ▶️ Watch the full interview now on DailyCardiology.com Hosted on SHENOTO

    Beyond the Guidelines: Peripheral Artery Disease

  3. 1d ago

    ESC 2026: Immediate ambulatory ECG monitoring vs standard care in unexplained syncope

    📚 ESC 2026 coverage: In unexplained syncope, does immediate 14-day ECG monitoring reduce recurrence compared with standard care? By Dr. Eftekharzadeh, fellowship of electrophysiology. Hosted on SHENOTO

    ESC 2026: Immediate ambulatory ECG monitoring vs standard care in unexplained syncope

  4. 2d ago

    ESC 2026: Pulmonary vein isolation vs sham in AF

    📚 ESC 2026 coverage: Does catheter ablation truly improve symptoms in atrial fibrillation? by Dr. Bozorgi, fellowship of electrophysiology. Hosted on SHENOTO

    ESC 2026: Pulmonary vein isolation vs sham in AF

  5. 2d ago

    ESC 2026: Long-term blood pressure control and dementia risk

    📚 ESC 2026 coverage: Can better blood pressure control reduce the risk of dementia? by Dr. Yahyavi, internal medicine resident. Hosted on SHENOTO

    ESC 2026: Long-term blood pressure control and dementia risk

  6. 2d ago

    ESC 2026: Pacibekitug (IL-6 ligand mAb) in patients with CKD and high CV risk

    📚 ESC 2026 coverage: Can targeting IL-6 with pacibekitug reduce residual inflammatory risk in patients with CKD and high cardiovascular risk? by Dr. Mohammadi, clinical pharmacist. Hosted on SHENOTO

    ESC 2026: Pacibekitug (IL-6 ligand mAb) in patients with CKD and high CV risk

  7. 5d ago

    ESC 2026: Response-tailored duration of antibiotic treatment for infectious endocarditis

    📚 ESC 2026 coverage: Can a response-tailored shorter antibiotic strategy be a safe alternative to standard therapy in infective endocarditis? by Dr. Hafezi, general cardiologist. Hosted on SHENOTO

    ESC 2026: Response-tailored duration of antibiotic treatment for infectious endocarditis

  8. 5d ago

    ESC 2026: Implementation of SGLT2 inhibitors in patients with HF through a digital strategy

    📚 ESC 2026 coverage: How can a digital registry system improve the implementation of SGLT2 inhibitors in heart failure patients? by Dr. Taghavi, fellowship of heart failure. Hosted on SHENOTO

    ESC 2026: Implementation of SGLT2 inhibitors in patients with HF through a digital strategy
See All (793)

Ratings & Reviews

4.9
out of 5
8 Ratings

About

to enjoy learning and progressing in cardiometabolic practice برای تبلیغات صوتی و اسپانسرینگ پادکست‌های فارسی، به شنوتو مراجعه کنید. Hosted on SHENOTO

Information

  • Creator
    Daily Cardiology Academy
  • Years Active
    2022 - 2026
  • Episodes
    793
  • Rating
    Clean
  • Copyright
    © Daily Cardiology Academy
  • Show Website
    Daily Cardiology

You Might Also Like